Dashboard
Manage Tickers

XYL Xylem Inc.

NYSE xylem.com


$ 151.92 $ 0.00 (0 %)    

Monday, 10-Nov-2025 04:08:39 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 618.82 $ 0.00 (0 %)
DIA $ 471.48 $ 0.00 (0 %)
SPY $ 677.01 $ 0.00 (0 %)
TLT $ 89.04 $ 0.00 (0 %)
GLD $ 375.38 $ 0.00 (0 %)
$ 151.31
$ 149.67
$ 151.92 x 6
$ 153.40 x 114
-- - --
$ 99.88 - $ 154.27
1,020,830
na
36.84B
$ 1.09
$ 38.86
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-28-2025 09-30-2025 10-Q
2 07-31-2025 06-30-2025 10-Q
3 04-29-2025 03-31-2025 10-Q
4 03-03-2025 01-01-1970 10-K
5 10-31-2024 09-30-2024 10-Q
6 07-30-2024 06-30-2024 10-Q
7 05-02-2024 03-31-2024 10-Q
8 02-28-2024 12-31-2023 10-K
9 10-31-2023 09-30-2023 10-Q
10 08-04-2023 06-30-2023 10-Q
11 05-04-2023 03-31-2023 10-Q
12 02-24-2023 12-31-2022 10-K
13 11-01-2022 09-30-2022 10-Q
14 08-02-2022 06-30-2022 10-Q
15 05-04-2022 03-31-2022 10-Q
16 02-25-2022 12-31-2021 10-K
17 11-02-2021 09-30-2021 10-Q
18 08-03-2021 06-30-2021 10-Q
19 05-04-2021 03-31-2021 10-Q
20 02-26-2021 12-31-2020 10-K
21 10-29-2020 09-30-2020 10-Q
22 07-30-2020 06-30-2020 10-Q
23 05-05-2020 03-31-2020 10-Q
24 02-28-2020 12-31-2019 10-K
25 10-31-2019 09-30-2019 10-Q
26 08-01-2019 06-30-2019 10-Q
27 05-02-2019 03-31-2019 10-Q
28 02-22-2019 12-31-2018 10-K
29 10-30-2018 09-30-2018 10-Q
30 07-31-2018 06-30-2018 10-Q
31 05-01-2018 03-31-2018 10-Q
32 02-23-2018 12-31-2017 10-K
33 10-31-2017 09-30-2017 10-Q
34 08-01-2017 06-30-2017 10-Q
35 05-02-2017 03-31-2017 10-Q
36 02-23-2017 12-31-2016 10-K
37 11-01-2016 09-30-2016 10-Q
38 08-02-2016 06-30-2016 10-Q
39 05-03-2016 03-31-2016 10-Q
40 02-26-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

ubs-maintains-buy-on-xylem-raises-price-target-to-175
UBS Maintains Buy on Xylem, Raises Price T...
11/06/2025 18:06:54

UBS analyst Damian Karas maintains Xylem (NYSE:XYL) with a Buy and raises the price target from $168 to $175.

stifel-maintains-buy-on-xylem-raises-price-target-to-178
Stifel Maintains Buy on Xylem, Raises Pric...
10/29/2025 17:46:17

Stifel analyst Nathan Jones maintains Xylem (NYSE:XYL) with a Buy and raises the price target from $175 to $178.

rbc-capital-maintains-outperform-on-xylem-raises-price-target-to-176
RBC Capital Maintains Outperform on Xylem,...
10/29/2025 17:33:13

RBC Capital analyst Deane Dray maintains Xylem (NYSE:XYL) with a Outperform and raises the price target from $169 to $176.

heres-how-much-you-would-have-made-owning-xylem-stock-in-the-last-10-years
Here's How Much You Would Have Made Owning...
10/29/2025 14:00:37

barclays-maintains-overweight-on-xylem-raises-price-target-to-172
Barclays Maintains Overweight on Xylem, Ra...
10/29/2025 13:46:33

Barclays analyst William Grippin maintains Xylem (NYSE:XYL) with a Overweight and raises the price target from $165 to $172.

nasdaq-100-hits-26000-gold-falls-below-4000-whats-moving-markets-tuesday
Nasdaq 100 Hits 26,000, Gold Falls Below $...
10/28/2025 17:23:51

Tech stocks hit new highs as the Nasdaq 100 rallies 0.7% midday. Investors eye a Fed rate cut, Trump-Xi meeting, and major tech...

xylem-raises-outlook-as-ceo-hails-resilient-demand-and-record-profit-margins
Xylem Raises Outlook As CEO Hails Resilien...
10/28/2025 15:15:48

Xylem Inc. (NYSE: XYL) reported Q3 2025 results beating Wall Street estimates with $1.37 EPS and $2.27B in revenue.

earnings-scheduled-for-october-28-2025
Earnings Scheduled For October 28, 2025
10/28/2025 11:11:34

xylem-raises-fy2025-adj-eps-guidance-from-470-485-to-503-508-vs-484-est-raises-fy2025-sales-guidance-from-8900b-9000b-to-9000b-vs-8951b-est
Xylem Raises FY2025 Adj EPS Guidance from ...
10/28/2025 10:56:41

Xylem (NYSE:XYL) raises FY2025 Adj EPS guidance from $4.70-$4.85 to $5.03-$5.08 vs $4.84 analyst estimate. Raises FY2025 sales ...

xylem-q3-adj-eps-137-beats-123-estimate-sales-2268b-beat-2221b-estimate
Xylem Q3 Adj. EPS $1.37 Beats $1.23 Estima...
10/28/2025 10:55:37

Xylem (NYSE:XYL) reported quarterly earnings of $1.37 per share which beat the analyst consensus estimate of $1.23 by 11.11 per...

american-water-essential-utilities-unite-in-major-deal-to-reshape-us-water-market
American Water, Essential Utilities Unite ...
10/27/2025 16:13:23

American Water and Essential Utilities to merge, creating dominant, regulated water and wastewater utility with $40B market cap.

insights-into-xylems-upcoming-earnings
Insights into Xylem's Upcoming Earnings
10/27/2025 16:01:01

if-you-invested-100-in-xylem-stock-10-years-ago-you-would-have-this-much-today
If You Invested $100 In Xylem Stock 10 Yea...
10/23/2025 14:17:19

pe-ratio-insights-for-xylem
P/E Ratio Insights for Xylem
10/20/2025 16:42:41

what-8-analyst-ratings-have-to-say-about-xylem
What 8 Analyst Ratings Have To Say About X...
10/09/2025 22:01:24

citigroup-maintains-buy-on-xylem-raises-price-target-to-173
Citigroup Maintains Buy on Xylem, Raises P...
10/09/2025 17:30:14

Citigroup analyst Andrew Kaplowitz maintains Xylem (NYSE:XYL) with a Buy and raises the price target from $168 to $173.

deal-dispatch-from-stellantis-to-snyk-major-companies-consider-exits
Deal Dispatch: From Stellantis To Snyk, Ma...
10/03/2025 20:04:54

Berkshire agreed to buy OxyChem for $9.7 billion while EA goes private for $55 billion. Also, Middleby seeks a $800 million deal.

aurelius-to-acquire-international-division-of-xylems-water-metering-business-for-undisclosed-terms-deal-expected-to-close-in-q1-2026
AURELIUS To Acquire International Division...
10/02/2025 10:57:06

Xylem Inc. (NYSE:XYL), a leading global water solutions company, has entered into a definitive agreement for AURELIUS to acquir...

how-do-investors-really-feel-about-xylem
How Do Investors Really Feel About Xylem?
09/24/2025 15:00:58

barclays-initiates-coverage-on-xylem-with-overweight-rating-announces-price-target-of-165
Barclays Initiates Coverage On Xylem with ...
09/19/2025 12:12:47

Barclays analyst William Grippin initiates coverage on Xylem (NYSE:XYL) with a Overweight rating and announces Price Target ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION